DOI:
10.1055/s-00000012
Endoscopy
LinksClose Window
References
Pollack CV, Reilly PA, van Ryn J. et al.
Idarucizumab for dabigatran reversal - full cohort analysis.
NEJM 2017;
377: 431-441
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.